[go: up one dir, main page]

NO20015782D0 - Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri - Google Patents

Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri

Info

Publication number
NO20015782D0
NO20015782D0 NO20015782A NO20015782A NO20015782D0 NO 20015782 D0 NO20015782 D0 NO 20015782D0 NO 20015782 A NO20015782 A NO 20015782A NO 20015782 A NO20015782 A NO 20015782A NO 20015782 D0 NO20015782 D0 NO 20015782D0
Authority
NO
Norway
Prior art keywords
hyperoxaluria
prevention
composition
treatment
pharmaceutical composition
Prior art date
Application number
NO20015782A
Other languages
English (en)
Other versions
NO20015782L (no
Inventor
Claudio De Simone
Original Assignee
Vsl Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsl Pharma Ltd filed Critical Vsl Pharma Ltd
Publication of NO20015782D0 publication Critical patent/NO20015782D0/no
Publication of NO20015782L publication Critical patent/NO20015782L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
NO20015782A 1999-05-28 2001-11-27 Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri NO20015782L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
PCT/IT2000/000213 WO2000072855A2 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria

Publications (2)

Publication Number Publication Date
NO20015782D0 true NO20015782D0 (no) 2001-11-27
NO20015782L NO20015782L (no) 2002-01-25

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015782A NO20015782L (no) 1999-05-28 2001-11-27 Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri

Country Status (34)

Country Link
US (2) US6562336B2 (no)
EP (1) EP1181027B1 (no)
JP (1) JP4737836B2 (no)
KR (1) KR100781703B1 (no)
CN (1) CN100350919C (no)
AR (1) AR024555A1 (no)
AT (1) ATE265857T1 (no)
AU (1) AU773459B2 (no)
BR (1) BR0011038B1 (no)
CA (1) CA2373255C (no)
CZ (1) CZ20014076A3 (no)
DE (1) DE60010456T2 (no)
DK (1) DK1181027T3 (no)
DZ (1) DZ3165A1 (no)
EA (1) EA004257B1 (no)
EE (1) EE200100618A (no)
ES (1) ES2219344T3 (no)
HK (1) HK1048066B (no)
HU (1) HU225134B1 (no)
IL (3) IL146703A0 (no)
IS (1) IS6150A (no)
IT (1) IT1309427B1 (no)
MA (1) MA26790A1 (no)
MX (1) MXPA01012184A (no)
NO (1) NO20015782L (no)
NZ (1) NZ516020A (no)
PL (1) PL352014A1 (no)
PT (1) PT1181027E (no)
SI (1) SI1181027T1 (no)
SK (1) SK16612001A3 (no)
TR (1) TR200103439T2 (no)
UA (1) UA71621C2 (no)
WO (1) WO2000072855A2 (no)
ZA (1) ZA200110504B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
AU2004249060A1 (en) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
WO2005089564A1 (en) 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
EP1814995A2 (en) * 2004-10-27 2007-08-08 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
CA2609617C (en) 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
PT1962873E (pt) * 2005-12-14 2013-08-29 Oxthera Inc Composições farmacêuticas compreendendo bactérias redutoras de oxalato
CN101405022A (zh) 2005-12-16 2009-04-08 奥克斯赛拉公司 用于减少草酸盐的组合物和方法
AU2008230747A1 (en) * 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
US9283252B2 (en) 2008-09-30 2016-03-15 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
JP5765832B2 (ja) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
CA2963213C (en) * 2014-10-01 2021-02-09 Triphase Pharmaceuticals Pvt. Ltd. Thermo-stable lactobacillus strains, products and methods thereof
ITUB20155752A1 (it) 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
CN107868775A (zh) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 草酸脱羧酶的制备及其制品和应用
WO2018125735A1 (en) 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
JP2022512380A (ja) * 2018-12-10 2022-02-03 ノヴォム バイオテクノロジーズ，インコーポレイテッド 高シュウ酸尿症を治療するための方法及び組成物
AU2021207879A1 (en) * 2020-01-14 2022-09-08 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
CN113308416B (zh) * 2021-07-20 2023-02-24 四川大学 一株具有抑制肾结石形成能力的植物乳杆菌及其应用
CN115851508B (zh) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
EP0577904B1 (fr) * 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Bactérie lactique
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia-Yomo S.P.A., Mailand/Milano Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
AU7590798A (en) * 1997-05-23 1998-12-11 Ixion Biotechnology, Inc. Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
RU2139346C1 (ru) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии

Also Published As

Publication number Publication date
EA004257B1 (ru) 2004-02-26
PT1181027E (pt) 2004-09-30
BR0011038A (pt) 2002-02-26
JP2003500451A (ja) 2003-01-07
EE200100618A (et) 2003-02-17
HU225134B1 (en) 2006-06-28
SI1181027T1 (en) 2004-08-31
BR0011038B1 (pt) 2014-02-18
US6562336B2 (en) 2003-05-13
EP1181027A2 (en) 2002-02-27
HK1048066A1 (zh) 2003-03-21
DE60010456T2 (de) 2005-05-12
USRE39585E1 (en) 2007-04-24
IL199437A0 (en) 2011-07-31
KR20020019918A (ko) 2002-03-13
MXPA01012184A (es) 2003-06-30
IL146703A (en) 2010-03-28
PL352014A1 (en) 2003-07-14
AR024555A1 (es) 2002-10-16
IT1309427B1 (it) 2002-01-23
HK1048066B (zh) 2008-08-01
ITRM990338A1 (it) 2000-11-28
AU773459B2 (en) 2004-05-27
ITRM990338A0 (it) 1999-05-28
DE60010456D1 (de) 2004-06-09
MA26790A1 (fr) 2004-12-20
CZ20014076A3 (cs) 2002-03-13
IS6150A (is) 2001-11-08
NZ516020A (en) 2003-06-30
HUP0201409A2 (en) 2002-08-28
SK16612001A3 (sk) 2002-04-04
ZA200110504B (en) 2002-09-25
US20020061292A1 (en) 2002-05-23
IL199437A (en) 2016-10-31
WO2000072855A2 (en) 2000-12-07
KR100781703B1 (ko) 2007-12-03
EA200101262A1 (ru) 2002-04-25
TR200103439T2 (tr) 2002-06-21
UA71621C2 (en) 2004-12-15
ATE265857T1 (de) 2004-05-15
CN100350919C (zh) 2007-11-28
ES2219344T3 (es) 2004-12-01
AU5101600A (en) 2000-12-18
DK1181027T3 (da) 2004-08-16
WO2000072855A3 (en) 2001-06-28
IL146703A0 (en) 2002-07-25
EP1181027B1 (en) 2004-05-06
CA2373255A1 (en) 2000-12-07
JP4737836B2 (ja) 2011-08-03
CN1365284A (zh) 2002-08-21
NO20015782L (no) 2002-01-25
HUP0201409A3 (en) 2004-10-28
CA2373255C (en) 2010-01-19
DZ3165A1 (fr) 2000-12-07

Similar Documents

Publication Publication Date Title
NO20015782D0 (no) Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
HRP20030046A2 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
NO995500D0 (no) Anvendelse av en farmasöytisk sammensetning til behandling av/eller forhindring av ischemi
WO2000066104A3 (en) Ace-2 inhibiting compounds and methods of use thereof
IL164022A0 (en) Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
IL145012A0 (en) Fluorine substituted triarylmethane derivatives and pharmaceutical compositions containing the same
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
IL157441A0 (en) Cyano-substituted dihydropyrimidine derivatives and pharmaceutical compositions containing the same
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
PL354413A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts ofginkgo biloba
HUP0401484A3 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine and pharmaceutical compositions containing the combination
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
IL162743A0 (en) Tricyclic 2-pyrimidone derivatives and pharmaceutical compositions containing the same
NO20012428D0 (no) Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
IT1306179B1 (it) Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
IL159614A0 (en) Benzofuran derivatives and pharmaceutical compositions containing the same
HUP0002154A3 (en) Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression
DK1140090T3 (da) Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt
IL137190A0 (en) Pharmaceutical compositions for the treatment of dyskinesias

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application